How much does Pembrolizumab cost?

Pembrolizumab is widely used in the treatment of a variety of malignant tumors, including melanoma, non-small cell lung cancer, kidney cancer, head and neck squamous cell carcinoma, etc. It can be used as a component of the first-line or late-line treatment plan, or can be used in combination with chemotherapy, radiotherapy or other immunotherapies. It is usually given to patients by intravenous injection and monitored by professional doctors.

Pembrolizumab is an immunotherapy drug that belongs to the immune checkpoint inhibitor class. Its mechanism of action is to enhance the body's immune system's ability to attack cancer cells by inhibiting a protein in the immune system called PD-1 (programmed death-1). Some types of cancer cells evade immune system attack by overexpressing PD-L1, and pembrolizumab works by blocking the interaction between PD-1 and PD-L1, thereby lifting the cancer cells' inhibition of immune attack. Common adverse reactions may include fatigue, nausea, rash, vomiting, diarrhea, fever, etc., but these adverse reactions are usually mild and reversible.

PembrolizumabThe original drug is already on the market in China. SpecificationsThe price per box of 100mg/4ml may be around RMB 15,000. This drug is a strictly controlled drug and has not yet been included in medical insurance. Pembrolizumab The price of the European version of the original drug 100mg/4ml per box may be around RMB 25,000, and the price of the Turkish version of 100mg/4ml per box may be around 10,000 RMB (the price may fluctuate due to the exchange rate). The ingredients of the original drugs at home and abroad are basically the same, and they are expensive. There are currently no generic versions of Pembrolizumab available overseas.